Open Access. Powered by Scholars. Published by Universities.®
- Institution
- Keyword
-
- Public health services and systems research (29)
- Practice-Based Research Networks (24)
- Public health economics (19)
- Practice-based research networks (9)
- Public Health (9)
-
- Health Services Research (4)
- Public Health Delivery (4)
- Value (4)
- Empirical likelihood (3)
- Evidence (3)
- PBRNs (3)
- ROI (3)
- Bayesian (2)
- COVID-19 (2)
- Cancer (2)
- Economics (2)
- Funding (2)
- Generalized estimating equations (2)
- Longitudinal data (2)
- Malaria (2)
- Public Health Spending (2)
- Public health (2)
- Regionalization (2)
- Research Needs (2)
- Return on Investment (2)
- Sexuality and the Law (2)
- Uncertainties (2)
- Women (2)
- Accreditation (1)
- Aging (1)
- Publication Year
- Publication
Articles 61 - 62 of 62
Full-Text Articles in Econometrics
Two Hundred Gastrointestinal Stromal Tumors: Recurrence Patterns And Prognostic Factors For Survival, Ronald P. Dematteo, Jonathan J. Lewis, Denis H. Y. Leung, Salvinder S. Mudan, James M. Woodruff, Murray F. Brennan
Two Hundred Gastrointestinal Stromal Tumors: Recurrence Patterns And Prognostic Factors For Survival, Ronald P. Dematteo, Jonathan J. Lewis, Denis H. Y. Leung, Salvinder S. Mudan, James M. Woodruff, Murray F. Brennan
Research Collection School Of Economics
Objective: To analyze the outcome of 200 patients with gastrointestinal stromal tumor (GIST) who were treated at a single institution and followed up prospectively. Summary Background Data: A GIST is a visceral sarcoma that arises from the gastrointestinal tract. Surgical resection is the mainstay of treatment because adjuvant therapy is unproven. Methods: Two hundred patients with malignant GIST were admitted and treated at Memorial Hospital during the past 16 years. Patient, tumor, and treatment variables were analyzed to identify patterns of tumor recurrence and factors that predict survival. Results: Of the 200 patients, 46% had primary disease without metastasis, 47% …
Rearrangement Of The Bcl-6 Gene As A Prognostic Marker In Diffuse Large-Cell Lymphoma, K. Offit, D.C. Louie, N. Z. Parsa, Denis H. Y. Leung, C. Portlock, B.H. Ye, F. Lista, D.A. Filippa, A. Rosenbaum, M. Ladanyi, S. Jhanwar, R. Dalla-Favera, R.S.K. Changanti
Rearrangement Of The Bcl-6 Gene As A Prognostic Marker In Diffuse Large-Cell Lymphoma, K. Offit, D.C. Louie, N. Z. Parsa, Denis H. Y. Leung, C. Portlock, B.H. Ye, F. Lista, D.A. Filippa, A. Rosenbaum, M. Ladanyi, S. Jhanwar, R. Dalla-Favera, R.S.K. Changanti
Research Collection School Of Economics
Current therapy can induce a long-term remission in half the patients with diffuse lymphomas with a large-cell component (DLLC), but more intensive treatment has the potential to improve outcome. Rearrangement of a novel candidate proto-oncogene, bcl-6, correlates with a favorable clinical outcome in DLLC and may thus serve as a prognostic marker.